The Connections Between Pain and Itch: Shared Neuroimmune Mechanisms and Therapeutic Implications

Curr Pain Headache Rep. 2026 Apr 22;30(1):49. doi: 10.1007/s11916-026-01490-8.

Purpose of Review

Pain and itch are distinct somatosensory modalities with essential protective functions, yet they exhibit substantial neurobiological and clinical overlap. Although traditionally considered separate sensory systems, accumulating evidence indicates that nociception and pruritus are mediated and modulated by interacting neuronal populations, shared signaling pathways, and common inflammatory mechanisms. This review aims to synthesize current understanding of the convergent peripheral and central processes underlying pain and itch and to highlight their implications for diagnosis and treatment.

Recent Findings

Recent advances have identified overlapping molecular and cellular substrates involved in pain and itch processing, including transient receptor potential (TRP) channels, G-protein–coupled receptors (GPCRs), and neuroimmune signaling mediated by cytokines, mast cells, and glial activation. At the spinal level, inhibitory gating mechanisms that suppress itch in response to noxious stimuli have been elucidated, as well as maladaptive plasticity contributing to central sensitization in chronic pain and chronic pruritus states. Clinically, these shared mechanisms manifest across diverse conditions, including neuropathic disorders, dermatologic diseases, and systemic illnesses, complicating phenotypic differentiation between pain-dominant and itch-dominant presentations. Therapeutic strategies increasingly target overlapping pathways, encompassing gabapentinoids, opioid-modulating agents, biologic therapies, and emerging gene-silencing approaches.

Summary

Pain and itch represent interconnected sensory experiences supported by shared neurobiological substrates rather than fully independent systems. Integrating mechanistic insights with clinical phenotyping provides a unified framework for understanding these modalities and highlights opportunities for mechanism-based, cross-modal therapeutic strategies. Such an approach may improve diagnostic accuracy and optimize treatment outcomes for complex sensory disorders characterized by overlapping pain and itch phenotypes.

PMID:42014517 | DOI:10.1007/s11916-026-01490-8